UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
N. Korea’s infant mortality 8 times higher than that of S. Korea but declining
North Korea’s infant mortality is higher than that of South Korea by eight ...
by Song Soo-youn
|
2018-08-02 15:28
라인
Government to cut tuberculosis rate to half by 2022
The Ministry of Health and Welfare and the Korea Centers for Disease Contro...
by Marian Chu
|
2018-08-02 10:44
라인
Korean expert weighs in on ‘gaming disorder’ as mental health issue
Shock rippled through society in 2010, when a 19-year-old adolescent died s...
by Marian Chu
|
2018-08-02 10:43
라인
‘Strong grip improves quality of life’
Professor Park Hye-soon Researchers at Asan Medical Center (AMC) have dis...
by Lee Han-soo
|
2018-08-01 17:48
라인
Daewoong Bio’s dementia drug hits 3-digit sales growth
Industry watchers are paying attention to whether rising sales of generic d...
by So Jae-hyeon
|
2018-08-01 15:50
라인
Health insurance service center set up for expats
The National Health Insurance Service (NHIS) said it has established a heal...
by Lee Min-ju
|
2018-08-01 15:42
라인
GC increases in sales but loses profit in Q2
GC and its affiliates managed to increase its sales in the second quarter o...
by Lee Han-soo
|
2018-08-01 15:14
라인
Celltrion clears final Inflectra patent hurdle
Celltrion won the last patent battle for its biologic drug Inflectra (infli...
by Marian Chu
|
2018-08-01 15:12
라인
Hanmi posts ₩243.1 billion in Q2 sales
Hanmi Pharmaceutical said Tuesday that it recorded 243.1 billion won ($217....
by Lee Han-soo
|
2018-08-01 14:38
라인
Drunkard attacks ER intern with metal tray
A drunken patient assaulted an intern doctor in the head with a metal tray ...
by Song Soo-youn
|
2018-08-01 11:54
라인
‘Roche Korea’s Alecensa effective against central nervous system disease risk’
Roche Korea’s lung cancer therapy Alecensa (alectinib) proved itself to sta...
by Marian Chu
|
2018-07-31 17:57
라인
AMC treats Egyptian surgeon with multiple hepatocellular carcinomas
Professor Kim Ki-hun has a conversation with Shananm Mohamed after completi...
by Lee Han-soo
|
2018-07-31 17:50
라인
Genematrix’s bacterial vaginosis detection kit gets sales approval
Genematrix said Monday it has won the government’s approval for NeoPlex STI...
by Lee Han-soo
|
2018-07-31 15:39
라인
Sales of osteoporosis drugs falter, combo therapies survive
The osteoporosis treatment market is stagnating with sales of major product...
by So Jae-hyeon
|
2018-07-31 15:37
라인
Eli Lilly Korea gets reimbursement for psoriasis treatment Taltz
The Korean branch of Eli Lilly and Company said Tuesday that it gained reim...
by Marian Chu
|
2018-07-31 14:03
라인
2018-listed pharmaceutical, medical shares tank
With pharmaceutical and medical device stocks tumbling in Seoul, share pric...
by Nam Doo-hyun
|
2018-07-31 14:02
라인
SillaJen, Medytox one step closer to entering China
Korean biotech firms SillaJen and Medytox said they have almost completed p...
by So Jae-hyeon
|
2018-07-31 13:09
라인
Rayence posts ₩30.7 billion in Q2 sales
Rayence, a Korean company specializing in digital X-ray imaging solution, s...
by Lee Han-soo
|
2018-07-30 17:02
라인
‘Punishment on Anaki operator too weak’
A South Korean court sentenced a jail term to the operator of “Anaki,” the ...
by Choi Gwang-seok
|
2018-07-30 15:40
라인
Medpacto to collaborate on immunotherapy with big pharma companies
Medpacto, a subsidiary of Theragen Etex, is increasing its presence in the ...
by Lee Han-soo
|
2018-07-30 15:20
-
이전
191
192
193
194
195
196
197
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top